#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute on chronic liver failure HER2 gene amplification Hepatic angiosarcoma Anti-HLA antibody test positive Usher's syndrome Neurodevelopmental disorder Pleural mesothelioma malignant Thromboangiitis obliterans Acquired C1 inhibitor deficiency Haemophilia Retinal dystrophy Fatty acid oxidation disorder Autoimmune myositis Infective uveitis Subarachnoid haemorrhage More trials…

    Learn about Rare Diseases

    Fabry’s disease Lymphangioma – Treatment Friedreich’s ataxia Soft tissue sarcoma – Basic Information Proteus syndrome – Life with Disease Shprintzen-Goldberg syndrome – Treatment Phenylketonuria – Treatment Lennox-Gastaut syndrome – Diagnostics Mucopolysaccharidosis – Basic Information X-linked lymphoproliferative syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo18A Repotrectinib Cetirizine Dihydrochloride Codeine Phosphate Human Von Willebrand Factor RIVASTIGMINE ZIRCONIUM (89ZR) GIRENTUXIMAB Orismilast Baricitinib Guselkumab Desoximetasone Teicoplanin Anhydrous Caffeine Vosilasarm Lecanemab Caraway Oil Plasma Imipenem Monohydrate GOVORESTAT Enfuvirtide More therapies…

    Learn about Your Condition

    Colorectal cancer stage III Ocular lymphoma Senile dementia Optic glioma Dermatomyositis Nephrolithiasis Metastases to peritoneum Rosai-Dorfman syndrome Nasopharyngeal cancer Pharyngeal cancer stage I Coma Seizure Endometrial adenocarcinoma Hyperkalaemia Type V hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Postoperative oxaliplatin liver‑directed chemotherapy plus drug combination in patients with resected colorectal liver metastases at high risk of recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Folinic Acid
    France

  • Evaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    • Mepolizumab
    • Benralizumab
    The Netherlands

  • Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Rituximab
    Sweden

  • Evaluation of zirconium-89 crefmirlimab berdoxam PET imaging for monitoring renal allograft rejection in kidney transplant recipients

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    The Netherlands

  • Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Tinzaparin Sodium
    • Dalteparin Sodium
    • Rivaroxaban
    Denmark

  • Phase I/II Study of ubamatamab plus drug combination in patients with ovarian cancer who have poor response to first‑line chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Ubamatamab
    • Bevacizumab
    • Carboplatin
    France
Previous Page
1 … 700 701 702 703 704 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!